Form 8-K - Current report:
SEC Accession No. 0001558370-19-006015
Filing Date
2019-07-03
Accepted
2019-07-03 16:15:27
Documents
3
Period of Report
2019-07-02
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K f8-k.htm 8-K 43412
2 EX-99.1 ex-99d1.htm EX-99.1 10778
3 GRAPHIC ex-99d1g001.jpg GRAPHIC 19277
  Complete submission text file 0001558370-19-006015.txt   82140
Mailing Address 640 LEE ROAD SUITE 200 WAYNE PA 19087
Business Address 640 LEE ROAD SUITE 200 WAYNE PA 19087 484-324-7933
Aclaris Therapeutics, Inc. (Filer) CIK: 0001557746 (see all company filings)

EIN.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37581 | Film No.: 19942057
SIC: 2834 Pharmaceutical Preparations